Opportunities to Network, Meet with Leaders of Tax Credit Community, Discuss Legislation and More, Oct. 23-24, 2025 SAN FRANCISCO, Sept. 12, 2025 /PRNewswire/ — Leaders in the new markets tax credit (NMTC) community will discuss the permanence of the incentive and convene at the Novogradac 2025 Fall New Markets Tax Credit Conference, held Oct. 23-24… Continue reading Novogradac New Markets Tax Credit Conference in New Orleans to Discuss Navigation of Permanence for the Incentive, More
Tag: Morgan
Bladex Successfully Launches Inaugural US$200 Million AT1 Notes Offering, Attracting Strong Global Investor Demand
PANAMA CITY, Sept. 12, 2025 /PRNewswire/ — Bladex today announced the successful pricing of its inaugural Additional Tier 1 (AT1) capital offering in the international markets, raising US$200 million. The perpetual, non-cumulative instruments, with an initial call date set for seven years, were priced at a 7.50% coupon and attracted significant interest from a broad… Continue reading Bladex Successfully Launches Inaugural US$200 Million AT1 Notes Offering, Attracting Strong Global Investor Demand
Přední evropský výrobce generik Zentiva mění vlastníka – Advent prodává firmu společnosti GTCR
PRAHA, LONDÝN a CHICAGO, 12. září 2025 /PRNewswire/ — Přední evropský výrobce generik Zentiva a investiční společnosti Advent a GTCR, významní globální hráči na poli private equity, dnes oznámili, že Advent prodává svůj podíl v Zentivě společnosti GTCR. Od akvizice Zentivy od společnosti Sanofi v roce 2018 spolupracoval Advent úzce s vedením firmy na úspěšné… Continue reading Přední evropský výrobce generik Zentiva mění vlastníka – Advent prodává firmu společnosti GTCR
Zentiva, ein führendes europäisches Generikaunternehmen, gibt den Verkauf von Advent an GTCR bekannt
PRAG, LONDON und CHICAGO, 12. September 2025 /PRNewswire/ — Zentiva, ein führendes europäisches Generikaunternehmen, Advent und GTCR – zwei weltweit führende Private-Equity-Investoren – geben heute den Verkauf von Zentiva durch Advent an GTCR bekannt. Seitdem Advent im Jahr 2018 Zentiva von Sanofi übernommen hat, arbeitet das Unternehmen eng mit dem Managementteam zusammen, um das Geschäft… Continue reading Zentiva, ein führendes europäisches Generikaunternehmen, gibt den Verkauf von Advent an GTCR bekannt
Gemini Announces Pricing of Initial Public Offering
NEW YORK, Sept. 11, 2025 /PRNewswire/ — Gemini Space Station, Inc. (“Gemini”), a global crypto platform, today announced the pricing of its initial public offering of 15,178,572 shares of Class A common stock at a public offering price of $28.00 per share. In connection with the offering, Gemini and the selling stockholders intend to grant… Continue reading Gemini Announces Pricing of Initial Public Offering
Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock
SAN DIEGO, Sept. 11, 2025 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced the pricing of its upsized underwritten public offering of 15,000,000 shares of its common stock at a price to the public of $40.00 per share. All of… Continue reading Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock
Amazfit Announces Olympic Medalist Grant Fisher as New Brand Ambassador
Elite distance runner joins Amazfit’s growing athlete team and will play an active role in product testing and innovation MILPITAS, Calif., Sept. 11, 2025 /PRNewswire/ — Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), today announced two-time Olympic medalist and American record holder Grant Fisher as the newest addition to its… Continue reading Amazfit Announces Olympic Medalist Grant Fisher as New Brand Ambassador
Zentiva, l’un des principaux fabricants européens de médicaments génériques, annonce sa vente à GTCR par Advent
PRAGUE, LONDRES et CHICAGO, 11 septembre 2025 /PRNewswire/ — Zentiva, société pharmaceutique européenne de premier plan spécialisée dans les médicaments génériques, Advent et GTCR, deux investisseurs privés mondiaux majeurs, annoncent aujourd’hui la vente de Zentiva à GTCR par Advent. Depuis l’acquisition de Zentiva auprès de Sanofi en 2018, Advent a travaillé en étroite collaboration avec… Continue reading Zentiva, l’un des principaux fabricants européens de médicaments génériques, annonce sa vente à GTCR par Advent
Zentiva, una compañía farmacéutica líder de genéricos en Europa, anuncia la venta de Advent a GTCR
PRAGA, LONDRES y CHICAGO, 11 de septiembre de 2025 /PRNewswire/ — Zentiva, una compañía farmacéutica líder de genéricos en Europa, Advent y GTCR, dos inversores líderes mundiales de capital privado, anunciaron hoy la venta de Zentiva por parte de Advent a GTCR. Desde la adquisición de Zentiva de Sanofi en 2018, Advent ha colaborado estrechamente con… Continue reading Zentiva, una compañía farmacéutica líder de genéricos en Europa, anuncia la venta de Advent a GTCR
Chinese EV Firm Nio Raises $1 Billion in Share Sale
The NIO Inc. logo. (Bloomberg) — Nio Inc. raised about $1 billion through a share sale, as the Chinese electric-vehicle maker takes advantage of a recent stock rally to fund its growth. The Shanghai-based EV maker sold about 181.8 million new shares at HK$43.36 ($5.57) the company said in a statement. Nio said it will… Continue reading Chinese EV Firm Nio Raises $1 Billion in Share Sale